Iv. Voltchek et al., POTENTIAL THERAPEUTIC EFFICACY OF UKRAIN (NSC-631570) IN AIDS PATIENTS WITH KAPOSIS-SARCOMA, Drugs under experimental and clinical research, 22(3-5), 1996, pp. 283-286
In this study two case reports are presented of therapy with Ukrain, a
semi-synthetic thiophosphoric acid compound of alkaloids isolated fro
m Chelidonium majus L., for the treatment of AIDS patients with Kaposi
's sarcoma. Ukrain was injected i.v. in the dose of 5 mg every other d
ay for a total of 10 injections. During treatment the Kaposi's sarcoma
lesions diminished in size, showed decolouration and no lesion appear
ed in the 30-day interval after the beginning oi treatment. Both patie
nts tolerated Ukrain well and showed an improved immunohaematological
status: an increase in total leukocytes, T-lymphocytes and T-supressor
numbers. In one case T-helper lymphocytes were also increased. Future
investigations are necessary for the evaluation of Ukrain efficacy in
the treatment of this type of patients.